Apex Biotechnology Corp. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 465.758 million compared to TWD 555.348 million a year ago. Operating income was TWD 2.865 million compared to TWD 100.989 million a year ago. Net loss was TWD 16.618 million compared to net income of TWD 70.426 million a year ago. Basic loss per share was TWD 0.17 compared to basic earnings per share of TWD 0.71 a year ago. Diluted loss per share was TWD 0.17 compared to diluted earnings per share of TWD 0.63 a year ago. For the nine months, sales was TWD 1,532.452 million compared to TWD 1,523.665 million a year ago. Operating income was TWD 67.931 million compared to TWD 178.759 million a year ago. Net income was TWD 33.069 million compared to TWD 132.295 million a year ago. Basic earnings per share was TWD 0.33 compared to TWD 1.33 a year ago. Diluted earnings per share was TWD 0.32 compared to TWD 1.22 a year ago.